Saswati Hazra - Concepedia

Author

Saswati Hazra

Exelixis (United States)

Also Known As

Rippe, Richard A, S Hazra, S. Hazra, SABYASACHI HAZRA, Sabyasachi Hazra, Saswati Hazra, Wang, Jiaohong

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Exelixis (United States)VA Greater Los Angeles Healthcare System National Taiwan University Hospital UCSF Helen Diller Family Comprehensive Cancer Center University of Southern California

About

Saswati Hazra is an author at Exelixis (United States) specializing in medicine, cell biology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	754
2	Cell Biology	5	5	621
3	Health Sciences	3	3	344
4	Gastroenterology	1	1	31
5	Health Policy	1	1	20

Saswati Hazra

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial Robin Kate Kelley, Lorenza Rimassa, Ann‐Lii Cheng, The Lancet Oncology	2022	494
mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in <i>PIK3CA</i> -Mutant Breast Cancer Moshe Elkabets, Sadhna Vora, Dejan Juric, Science Translational Medicine	2013	344
Peroxisome Proliferator-activated Receptor γ Induces a Phenotypic Switch from Activated to Quiescent Hepatic Stellate Cells Saswati Hazra, Shigang Xiong, Jiaohong Wang, Journal of Biological Chemistry	2004	308
Adipogenic Transcriptional Regulation of Hepatic Stellate Cells Hongyun She, Shigang Xiong, Saswati Hazra, Journal of Biological Chemistry Hepatic Stellate CellsFatty Liver DiseaseInsulin SignalingOxidative StressMetabolic Syndrome	2004	293
Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer Jessica J. Tao, Pau Castel, Nina Radosevic‐Robin, Science Signaling Breast OncologyOncologySignaling PathwayMedicineReceptor Tyrosine Kinase	2014	164
Pioglitazone and Rosiglitazone Decrease Prostaglandin E2 in Non–Small-Cell Lung Cancer Cells by Up-Regulating 15-Hydroxyprostaglandin Dehydrogenase Saswati Hazra, Raj K. Batra, Hsin Tai, Molecular Pharmacology	2007	87
Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell Carcinoma Maie A. St. John, Mariam Dohadwala, Jie Luo, Clinical Cancer Research	2009	86
VP10-2021: Cabozantinib (C) plus atezolizumab (A) versus sorafenib (S) as first-line systemic treatment for advanced hepatocellular carcinoma (aHCC): Results from the randomized phase III COSMIC-312 trial Robin Kate Kelley, Thomas Yau, Ann‐Lii Cheng, Annals of Oncology OncologyHepatologyMedicineFirst-line Systemic TreatmentPathology	2021	82
PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. Felicita Baratelli, Jay M. Lee, Saswati Hazra, PubMed Tgf-beta ConcentrationLung InflammationT-regulatory CellImmunologyRegulatory T Cells	2010	68
Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer Xiaoyan Cui, L Zhang, Jie Luo, Oncogene Tumor BiologyCyclooxygenase-2 ExpressionOncogenic AgentMedicinePathology	2007	66

Page 1